Douglas A. Levine, MD
Associate Member
Memorial Sloan Kettering Cancer Center
Gynecology Service/Dept. of Surgery
1275 York Avenue
New York,
NY
USA
10065
Biographical Sketch: Dr. Douglas Levine is an Associate Attending Surgeon at Memorial Sloan-Kettering Cancer Center in New York City. Dr. Levine earned his medical doctorate in 1995 at Mount Sinai Medical Center, where he also completed a residency in obstetrics and gynecology. He went on to a clinical fellowship in gynecologic oncology at Memorial Sloan-Kettering and then spent 2 years as a postdoctoral research fellow, also at Memorial. In addition to a clinical practice, Dr. Levine is the current Head of the Gynecology Research Laboratory, where he studies the genomic science of ovarian and endometrial carcinoma. Dr. Levine is very active within the NIH-sponsored Cancer Genome Atlas project (TCGA). He serves as co-chair of the Ovarian and Endometrial Disease Working Groups and has been responsible for providing a translational focus to the genomic analyses of the projects. In addition to these responsibilities, Dr. Levine is a member of the editorial board of Gynecologic Oncology and a member of the Scientific Advisory Committee of the Ovarian Cancer Research Fund. He has authored or co-authored more than 90 peer-reviewed articles and two textbooks. Dr. Levine receives funding from the National Cancer Institute, the Department of Defense, Stand Up 2 Cancer, and the Gynecologic Oncology Group."
Papers:
123 - Featured Poster
Maximizing minimally invasive surgical approaches in the morbidly obese patient with newly diagnosed uterine cancer
191 - Poster Session A
PD-0332991, a cyclin-dependent kinase 4/6 inhibitor, is an active agent in uterine cancer cells
196 - Poster Session A
Gene expression profiles of high-grade serous ovarian cancers in patients with normal CA-125 levels at the time of recurrence
254 - Poster Session A
An analysis of the survival outcomes of video-assisted thoracic surgery in the primary management of patients with advanced ovarian, tubal, and peritoneal cancer
265 - Poster Session A
Somatic mutations in small cell carcinoma of the ovary
498 - Poster Session B
Does minimally invasive surgery compromise the oncologic outcome of women with high-risk non-endometrioid endometrial carcinomas
Moderator Introductions
Late Breaking Abstract 4
SMARCA4 Mutations in Small Cell Carcinoma of the Ovary
Late Breaking Abstract 5
Risk of developing uterine corpus cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations